These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16493449)

  • 1. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations.
    Medici V; Mascheretti S; Croucher PJ; Stoll M; Hampe J; Grebe J; Sturniolo GC; Solberg C; Jahnsen J; Moum B; Schreiber S; Vatn MH
    Eur J Hum Genet; 2006 Apr; 14(4):459-68. PubMed ID: 16493449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG; Gu X; Wintle RF; Liu X; van Oene M; Amos CI; Siminovitch KA
    Hum Mutat; 2006 Apr; 27(4):353-8. PubMed ID: 16450402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M; Corneliussen B; Costello CM; Waetzig GH; Mellgard B; Koch WA; Rosenstiel P; Albrecht M; Croucher PJ; Seegert D; Nikolaus S; Hampe J; Lengauer T; Pierrou S; Foelsch UR; Mathew CG; Lagerstrom-Fermer M; Schreiber S
    Nat Genet; 2004 May; 36(5):476-80. PubMed ID: 15107852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
    Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
    Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
    Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease.
    Biank V; Friedrichs F; Babusukumar U; Wang T; Stoll M; Broeckel U; Kugathasan S
    Am J Gastroenterol; 2007 Feb; 102(2):391-8. PubMed ID: 17156146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy.
    Van Limbergen J; Nimmo ER; Russell RK; Drummond HE; Smith L; Anderson NH; Davies G; Arnott ID; Wilson DC; Satsangi J
    Hum Mol Genet; 2007 Sep; 16(18):2175-86. PubMed ID: 17613538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
    Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs.
    Hradsky O; Lenicek M; Dusatkova P; Bronsky J; Nevoral J; Valtrova V; Kotalova R; Szitanyi P; Petro R; Starzykova V; Bortlik M; Vitek L; Lukas M; Cinek O
    Tissue Antigens; 2008 Jun; 71(6):538-47. PubMed ID: 18489434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients.
    Giachino D; van Duist MM; Regazzoni S; Gregori D; Bardessono M; Salacone P; Scaglione N; Sostegni R; Sapone N; Bresso F; Sambataro A; Gaia E; Pera A; Astegiano M; De Marchi M
    Eur J Hum Genet; 2004 Mar; 12(3):206-12. PubMed ID: 14747834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
    Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
    Brant SR; Wang MH; Rawsthorne P; Sargent M; Datta LW; Nouvet F; Shugart YY; Bernstein CN
    Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.